JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD
JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD
Not yet recruiting · NCT07115706 · Registry updated 2025-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD | Erosive Gastroesophageal Reflux Disease | Not yet recruiting | Not stated | 2025-08-14 | NCT07115706 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jeil Pharmaceutical Co., Ltd. | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||